4//SEC Filing
Cukier Herm 4
Accession 0001103021-19-000050
CIK 0001103021other
Filed
Dec 3, 7:00 PM ET
Accepted
Dec 4, 4:17 PM ET
Size
8.8 KB
Accession
0001103021-19-000050
Insider Transaction Report
Form 4
Cukier Herm
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Common Stock
2019-12-02$2.18/sh+38,461$83,845→ 74,842 total - Sale
Common Stock
2019-12-02$6.82/sh−38,461$262,304→ 36,381 total - Exercise/Conversion
Stock Options (right to buy)
2019-12-02−38,461→ 761,539 totalExercise: $2.18From: 2019-05-08Exp: 2028-06-04→ Common Stock (38,461 underlying)
Footnotes (2)
- [F1]On December 2, 2019, the Reporting Person sold an aggregate of 38,461 shares of the Issuer's Common Stock at a weighted average price of $6.82 per share. The highest sale price for the Common Stock was $6.85 per share and the lowest sale price was $6.81 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes.
- [F2]The option representing a right to purchase a total of 800,000 shares, became exercisable in three equal installments beginning May 8, 2019.
Documents
Issuer
BIODELIVERY SCIENCES INTERNATIONAL INC
CIK 0001103021
Entity typeother
Related Parties
1- filerCIK 0001739458
Filing Metadata
- Form type
- 4
- Filed
- Dec 3, 7:00 PM ET
- Accepted
- Dec 4, 4:17 PM ET
- Size
- 8.8 KB